Materials Map

Discover the materials research landscape. Find experts, partners, networks.

  • About
  • Privacy Policy
  • Legal Notice
  • Contact

The Materials Map is an open tool for improving networking and interdisciplinary exchange within materials research. It enables cross-database search for cooperation and network partners and discovering of the research landscape.

The dashboard provides detailed information about the selected scientist, e.g. publications. The dashboard can be filtered and shows the relationship to co-authors in different diagrams. In addition, a link is provided to find contact information.

×

Materials Map under construction

The Materials Map is still under development. In its current state, it is only based on one single data source and, thus, incomplete and contains duplicates. We are working on incorporating new open data sources like ORCID to improve the quality and the timeliness of our data. We will update Materials Map as soon as possible and kindly ask for your patience.

To Graph

1.080 Topics available

To Map

977 Locations available

693.932 PEOPLE
693.932 People People

693.932 People

Show results for 693.932 people that are selected by your search filters.

←

Page 1 of 27758

→
←

Page 1 of 0

→
PeopleLocationsStatistics
Naji, M.
  • 2
  • 13
  • 3
  • 2025
Motta, Antonella
  • 8
  • 52
  • 159
  • 2025
Aletan, Dirar
  • 1
  • 1
  • 0
  • 2025
Mohamed, Tarek
  • 1
  • 7
  • 2
  • 2025
Ertürk, Emre
  • 2
  • 3
  • 0
  • 2025
Taccardi, Nicola
  • 9
  • 81
  • 75
  • 2025
Kononenko, Denys
  • 1
  • 8
  • 2
  • 2025
Petrov, R. H.Madrid
  • 46
  • 125
  • 1k
  • 2025
Alshaaer, MazenBrussels
  • 17
  • 31
  • 172
  • 2025
Bih, L.
  • 15
  • 44
  • 145
  • 2025
Casati, R.
  • 31
  • 86
  • 661
  • 2025
Muller, Hermance
  • 1
  • 11
  • 0
  • 2025
Kočí, JanPrague
  • 28
  • 34
  • 209
  • 2025
Šuljagić, Marija
  • 10
  • 33
  • 43
  • 2025
Kalteremidou, Kalliopi-ArtemiBrussels
  • 14
  • 22
  • 158
  • 2025
Azam, Siraj
  • 1
  • 3
  • 2
  • 2025
Ospanova, Alyiya
  • 1
  • 6
  • 0
  • 2025
Blanpain, Bart
  • 568
  • 653
  • 13k
  • 2025
Ali, M. A.
  • 7
  • 75
  • 187
  • 2025
Popa, V.
  • 5
  • 12
  • 45
  • 2025
Rančić, M.
  • 2
  • 13
  • 0
  • 2025
Ollier, Nadège
  • 28
  • 75
  • 239
  • 2025
Azevedo, Nuno Monteiro
  • 4
  • 8
  • 25
  • 2025
Landes, Michael
  • 1
  • 9
  • 2
  • 2025
Rignanese, Gian-Marco
  • 15
  • 98
  • 805
  • 2025

Chen, Ya-Li

  • Google
  • 1
  • 6
  • 3

in Cooperation with on an Cooperation-Score of 37%

Topics

Publications (1/1 displayed)

  • 2024Conversion or Reversion of Interferon γ Release Assays for <i>Mycobacterium tuberculosis</i> Infection: A Systematic Review and Meta-analysis3citations

Places of action

Chart of shared publication
Nicol, Mark P.
1 / 2 shared
Zhang, Yan-An
1 / 1 shared
Wang, Maoshui
1 / 1 shared
Alene, Kefyalew Addis
1 / 1 shared
Gilmour, Beth
1 / 1 shared
Li-Hunnam, Jarrod
1 / 1 shared
Chart of publication period
2024

Co-Authors (by relevance)

  • Nicol, Mark P.
  • Zhang, Yan-An
  • Wang, Maoshui
  • Alene, Kefyalew Addis
  • Gilmour, Beth
  • Li-Hunnam, Jarrod
OrganizationsLocationPeople

article

Conversion or Reversion of Interferon γ Release Assays for <i>Mycobacterium tuberculosis</i> Infection: A Systematic Review and Meta-analysis

  • Nicol, Mark P.
  • Chen, Ya-Li
  • Zhang, Yan-An
  • Wang, Maoshui
  • Alene, Kefyalew Addis
  • Gilmour, Beth
  • Li-Hunnam, Jarrod
Abstract

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Interferon γ release assays (IGRAs) are widely used for diagnosis of latent tuberculosis infection. However, with repeated testing, IGRA transformation (conversion or reversion) may be detected and is challenging to interpret. We reviewed the frequency of and risk factors for IGRA transformation.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We screened public databases for studies of human participants that reported the frequency of IGRA transformation. We extracted study and participant characteristics, details of IGRA testing and results. We calculated the pooled frequency of IGRA transformation (and transient transformation) and examined associated risk factors.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The pooled frequency of IGRA conversion or reversion from 244 studies was estimated at 7.3% (95% confidence interval [CI], 6.1%–8.5%) or 22.8% (20.1%–25.7%), respectively. Transient conversion or reversion were estimated at 46.0% (95% CI, 35.7%–56.4%) or 19.6% (9.2%–31.7%) of conversion or reversion events respectively. Indeterminate results seldom reverted to positive (1.2% [95% CI, .1%–3.5%]). IGRA results in the borderline-positive or borderline-negative range were associated with increased risk of conversion or reversion (pooled odds ratio [OR] for conversion, 4.15 [95% CI, 3.00–5.30]; pooled OR for reversion, 4.06 [3.07–5.06]). BCG vaccination was associated with decreased risk of conversion (OR, 0.70 [95% CI, .56–.84]), cigarette smoking with decreased risk of reversion (0.44 [.06–.82]), and female sex with decreased risk of either conversion or reversion (OR for conversion, 0.66 [.58–.75]; OR for reversion, 0.46 [.31–.61]).</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>IGRA conversion is less common than reversion, and frequently transient. Research is needed to determine whether individuals with reversion would benefit from tuberculosis-preventive treatment. Retesting of people with indeterminate results is probably not indicated, because indeterminate results seldom revert to positive.</jats:p></jats:sec>

Topics
  • impedance spectroscopy
  • laser emission spectroscopy
  • size-exclusion chromatography
  • chemical ionisation